Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Sun Pharma. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Sun Pharma Global Inc. with 13 drug applications and 1 drug recall. The most recent is a drug recall dated Sep 26, 2014: Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles and 90-cou….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Sep 26, 2014 | Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count bottles and 90-count bottles, RX only, Manufactured for Sun Pharma GloClass II · Failed Dissolution Specifications; 12 month stability time point | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
